[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:non-malignant-disease":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Non-malignant disease",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05501756","Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation",[11],"Phase 2","RECRUITING","2026-08-26T02:15:52.238965Z","2026-05-05T02:43:28.743675Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05711732","Busulfan Sample Collection Study",[],"2026-08-26T02:15:43.339060Z","2026-05-13T02:55:06.372166Z",[],[]]